FDA.reportPublic FDA data

calcium glycerophosphate / monofluorophosphate / pyridoxine

RxCUI
1046422
RxNorm name
calcium glycerophosphate / monofluorophosphate / pyridoxine
Term type
MIN
Status
Active
Updated
2026-11-06 11:36:00

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122010
Active start
122010
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
calcium glycerophosphate1909
monofluorophosphate52885
pyridoxine684879

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRcalcium glycerophosphate / monofluorophosphate / pyridoxine1NAMES
RxNorm Namecalcium glycerophosphate / monofluorophosphate / pyridoxine1NAMES
TTYMIN1ATTRIBUTES
RxCUI10464221CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA01AACaries prophylactic agentsATC1-4sodium monofluorophosphate
ATCA12CDFluorideATC1-4sodium monofluorophosphate
ATCA11HAOther plain vitamin preparationsATC1-4pyridoxine
FDASPLD025101Vitamin B 6CHEMhas_chemical_structurepyridoxine
FDASPLN0000192800Vitamin B6 AnalogEPChas_epcpyridoxine
MEDRTD005459FluoridesCHEMhas_ingredientmonofluorophosphate
MEDRTD005459FluoridesCHEMhas_ingredientsodium monofluorophosphate
MEDRTD005994GlycerophosphatesCHEMhas_ingredientcalcium glycerophosphate
MEDRTD011736PyridoxineCHEMhas_ingredientpyridoxine
MEDRTD011736PyridoxineCHEMhas_ingredientpyridoxine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withcalcium glycerophosphate
MEDRTD004342Drug HypersensitivityDISEASEci_withpyridoxine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withpyridoxine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_preventpyridoxine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatpyridoxine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_preventpyridoxine hydrochloride
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatpyridoxine hydrochloride
MEDRTD004942Esophagitis, PepticDISEASEmay_treatcalcium glycerophosphate
MEDRTD006934HypercalcemiaDISEASEci_withcalcium glycerophosphate
MEDRTD006996HypocalcemiaDISEASEmay_treatcalcium glycerophosphate
MEDRTD017674HypophosphatemiaDISEASEci_withcalcium glycerophosphate
MEDRTD007669Kidney CalculiDISEASEci_withcalcium glycerophosphate
MEDRTD015663Osteoporosis, PostmenopausalDISEASEmay_treatcalcium glycerophosphate
MEDRTD012640SeizuresDISEASEmay_treatpyridoxine
MEDRTD012640SeizuresDISEASEmay_treatpyridoxine hydrochloride
MEDRTD026681Vitamin B 6 DeficiencyDISEASEmay_preventpyridoxine
MEDRTD026681Vitamin B 6 DeficiencyDISEASEmay_treatpyridoxine
MEDRTD026681Vitamin B 6 DeficiencyDISEASEmay_preventpyridoxine hydrochloride
MEDRTD026681Vitamin B 6 DeficiencyDISEASEmay_treatpyridoxine hydrochloride
MEDRTN0000000220Electrolyte ActivityMOAhas_moacalcium glycerophosphate
MEDRTN0000000163Enzyme InteractionsMOAhas_moapyridoxine hydrochloride
MEDRTN0000000163Enzyme InteractionsMOAhas_moapyridoxine
MEDRTN0000008312Bone Resorption AlterationPEhas_pecalcium glycerophosphate
MEDRTN0000008337Cellular Activity AlterationPEhas_pepyridoxine
MEDRTN0000008337Cellular Activity AlterationPEhas_pepyridoxine hydrochloride
MEDRTN0000009557Increased Renal PO4-- ExcretionPEhas_pecalcium glycerophosphate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_HUMAN_DRUGUS